Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience

Abstract Background Urothelial bladder carcinoma accounts for around 3.9% cases of all the male cancers in India. Non-muscle-invasive bladder carcinoma (NMIBC) is predominant group which constitute approximately three fourth of the urothelial bladder cancer. Intravesical BCG immunotherapy is the cor...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Vivek Sharma, Avinash P. S. Thakur, Vasantharaja Ramasamy, Pushpendra Kumar Shukla, Fanindra Singh Solanki, Arpan Choudhary, Prashant Patel
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	SpringerOpen 2020-12-01
Schriftenreihe:	African Journal of Urology
Schlagworte:	Intravesical BCG Tuberculosis Non-muscle-invasive bladder carcinoma BCG toxicity BCG cystitis
Online-Zugang:	https://doi.org/10.1186/s12301-020-00099-6
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!